Sugar alcohol sorbitol may increase the risk of developing steatotic liver disease
View as a Web Page
News Medical
 
  Hepatology Hepatology logo  
  The latest hepatology news from News Medical  
 Regenerative medicine offers a pathway toward curing type 1 diabetesRegenerative medicine offers a pathway toward curing type 1 diabetes
 
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells.
 
 
 Sugar alcohol sorbitol may increase the risk of developing steatotic liver diseaseSugar alcohol sorbitol may increase the risk of developing steatotic liver disease
 
Sweeteners such as aspartame, found in Equal packets, sucralose (Splenda), or sugar alcohols are often seen as healthier alternatives to food with refined sugar (glucose).
 
   Why soybean oil may fuel weight gainWhy soybean oil may fuel weight gain
 
Researchers investigate how soybean oil may disrupt fat metabolism to potentially increase the risk of obesity.
 
   Alcohol-related liver disease deaths surge with widening socioeconomic gapsAlcohol-related liver disease deaths surge with widening socioeconomic gaps
 
Researchers at Saint Louis University School of Medicine say deaths from alcohol-related liver disease have surged in recent years, and the increase is hitting people without a college degree the hardest.
 
   Blocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancerBlocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancer
 
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology.
 
 A personalized approach to treating pancreatic cancer
 
It's not surprising that pancreatic cancer is often referred to as a silent killer. With few early symptoms and an aggressive nature, it has one of the lowest survival rates of all cancers.
 
 
 Blocking a key cell pathway reduces muscle wasting in pancreatic cancer
 
Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could transform treatment for one of cancer's most devastating complications.
 
 
 Tianjin grading system improves prognosis prediction in pancreatic cancer
 
Tianjin grading system improves prognosis prediction in pancreatic cancerPancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025